Rewinkel J B, Lucas H, van Galen P J, Noach A B, van Dinther T G, Rood A M, Jenneboer A J, van Boeckel C A
NV Organon, Scientific Development Group, Oss, The Netherlands.
Bioorg Med Chem Lett. 1999 Mar 8;9(5):685-90. doi: 10.1016/s0960-894x(99)00069-4.
Replacement of the highly basic benzamidine moiety of NAPAP by the moderately basic 1-aminoisoquinoline moiety resulted in thrombin inhibitors with improved selectivity towards trypsin and enhanced Caco-2 cell permeability.
将 NAPAP 的高碱性苯甲脒部分替换为中等碱性的 1-氨基异喹啉部分,得到了对胰蛋白酶具有更高选择性且 Caco-2 细胞通透性增强的凝血酶抑制剂。